Amanda Francisco-Fortes
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas disease.
Journal: Antimicrobial agents and chemotherapy
Published: May 05, 2025
Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.
Journal: Clinical microbiology reviews
Published: November 15, 2024
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease.
Journal: PLoS neglected tropical diseases
Published: September 24, 2024
Dynamics of Trypanosoma cruzi infection in hamsters and novel association with progressive motor dysfunction.
Journal: PLoS neglected tropical diseases
Published: November 13, 2023
Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi.
Journal: International journal of molecular sciences
Published: May 28, 2021
Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B.
Journal: Antimicrobial agents and chemotherapy
Published: April 02, 2018
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence.
Journal: PLoS neglected tropical diseases
Published: October 06, 2014
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection.
Journal: Cellular microbiology
Published: February 19, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026